Market Overview

Notable Put Options Activity in Celldex Therapeutics

Shares of Celldex Therapeutics (NASDAQ: CLDX) are higher on the session by 0.82%, currently trading at $8.56. The stock has been moving largely lower over the past three weeks and is currently trading above the 50-day moving average.

Options traders are focusing on puts today. The strike seeing the heaviest action is the May 2012 $3.00 put, which has traded 2,500 times on open interest of 2,781 contracts.

The block traded at $0.10.

Put volume is outpacing call volume by 5 to 1.

Celldex Therapeutics, Inc. is a biopharmaceutical company, which applies its Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases.

Posted-In: Options Markets

 

Related Articles (CLDX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters